BioMarin Pharmaceutical (NASDAQ:BMRN): Q1 Non-GAAP EPS of $0.62 beats by $0.29; GAAP EPS of $0.44 beats by $0.40.
Revenue of $502.07M (+25.3% Y/Y) beats by $33.3M.
https://seekingalpha.com/news/3566349-biomarin-pharmaceutical-eps-beats-0_29-beats-on-revenue
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.